Trebe Biotech offers an innovative, high-throughput platform for the production of high-quality and complex recombinant proteins.
Trebe Biotech has raised $250K in total funding. The most recent round was Grant. The last funding was announced in November 2025.
Trebe Biotech's investors include SF500, Grow-NY.
Trebe Biotech is headquartered in Pergamino, Argentina.
Trebe Biotech offers an innovative, high-throughput platform for the production of high-quality and complex recombinant proteins.
Trebe Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trebe Biotech — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/trebe-biotech. Accessed August 13, 2026.
VCBacked. (2025). Trebe Biotech — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/trebe-biotech
{{cite web |title=Trebe Biotech — Funding & Investors |url=https://www.vcbacked.co/company/trebe-biotech |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated